Polysynaptic excitatory postsynaptic potentials that trigger spasms after spinal cord injury in rats are inhibited by 5-HT1B and 5-HT1F receptorsProgesterone reduces the effect of the serotonin 1B/1D receptor antagonist, GR 127935, on lordosis behavior.High-resolution imaging of brain 5-HT 1B receptors in the rhesus monkey using [11C]P943.Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.Activation of 5-HT1B receptors inhibits the vasodepressor sensory CGRPergic outflow in pithed rats.Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test.A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.Effects of systemic 5-HT(1B) receptor compounds on ventral tegmental area intracranial self-stimulation thresholds in rats.Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms.Serotonergic involvement in methamphetamine-induced locomotor activity: A detailed pharmacological studyThe 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes
P921
Q1949517-0D612012-B1F9-468E-B292-3BA146DD062CQ21108118-6B2EAF5B-7420-4580-A258-E452D3124E93Q21109363-B3C8AEB8-C412-4B08-BABD-9C5266F79C58Q21115043-B8176E5E-9FA1-4328-BF9A-068D9F402127Q21115046-79D7A329-D4EB-46B8-AEFD-E1821F63D931Q21115051-D67FA67E-5957-4340-A9AC-66CE144800D0Q21115052-E87F4CFE-6EEF-471C-93BD-F2B6EDF36B1DQ288797-4EFA499D-EE42-430A-B0A1-0142C65BB5C8Q4639596-C41B1F34-7BE5-4A89-9007-84B540441D71
P129
Q35160555-7E42C72F-3F36-4137-8FDD-CC585BA2B08FQ37151424-E021EA13-D2BE-44F8-8B1B-87A946836183Q37190456-82187D4F-7C2C-44C4-81E9-D8995FD298DFQ43084294-9A01FA24-281C-4D94-9D8B-04BC5D530DD6Q43102697-8764C8A7-A57E-4E1C-B310-66892D718062Q43156061-990A0AC0-7A85-43AD-B066-38FB623683A1Q43234169-A4CCC9E9-055B-4A9E-A352-4CE21D5E71C9Q46056200-9E0FDD39-36F1-4F0E-A421-B52354D7A3C3Q46168874-89D33BF0-C898-4E4E-BC56-0A64DB2453CBQ46828449-439DD612-8AF5-4292-BB97-C2BFC6BEA601Q60705089-3016C720-89F7-4CE0-A5BE-80E8800C948AQ83806016-1EC6C913-FC65-4869-9C2E-F7D511632218
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
GR-127,935
@sh
GR-127,935
@sr
gr-127935
@en
type
label
GR-127,935
@sh
GR-127,935
@sr
gr-127935
@en
altLabel
2'-Methyl-4'-(5-methyl-(1,2,4) ...... hylpiperazin-1-yl)phenyl)amide
@en
GR-127935
@en
GR127935
@en
prefLabel
GR-127,935
@sh
GR-127,935
@sr
gr-127935
@en
P129
P486
P592
P6366
P661
P662
P683
P129
P1579
P2067
P231
148672-13-3
P233
CC1=C(C=CC(=C1)C2=NOC(=N2)C)C3=CC=C(C=C3)C(=O)NC4=CC(=C(C=C4)OC)N5CCN(CC5)C
P234
1S/C29H31N5O3/c1-19-17-23(28-3 ...... 17-18H,13-16H2,1-4H3,(H,31,35)
P235
YDBCEBYHYKAFRX-UHFFFAOYSA-N
P274
C₂₉H₃₁N₅O₃
P2868
P3117
DTXSID90164044
P486
P592
CHEMBL15928
P6366
2777956734
P652
2LLH6CEB40